Skip to main content
ODYS
NASDAQ Technology

Odysight.ai Q3 Revenue Jumps to $424K; Nine-Month Loss Widens to $13.7M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Scientific Instrument Stocks · Technology
Sentiment info
Neutral
Importance info
7
Price
$1.76
Mkt Cap
$36.035M
52W Low
$1.64
52W High
$11.3
52W Position info
7.3% above low
Off High info
84% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

ODYS is trading near its 52-week low of $1.64 (7.3% above the low).

Summary

Odysight.ai's Q3 revenue nearly tripled year over year to $424 thousand, but the nine-month loss widened to $13.7 million and cash fell to $22.8 million, leaving roughly a year of runway. New bylaws also eliminate stockholder written consent.


Key Events · Earnings and Guidance · ODYS

  • Q3 Revenue Nearly Triples

    Revenue was $424 thousand for the three months ended September 30, 2026, versus $149 thousand a year earlier, driven by completion of ongoing projects and new project starts.

  • Nine-Month Loss Widens

    Net loss was $13.7 million for the nine months versus $12.8 million in 2025; revenue fell 64% to $926 thousand because 2025 included a one-time $1.69 million contract-liability derecognition.

  • Cash Down to $22.8M

    Cash and cash equivalents were $22.8 million at September 30, 2026, down from $25.7 million at December 31, 2025; management says this funds the operating plan for at least 12 months.

  • Backlog Rises to $16.0M

    Remaining performance obligations/backlog were approximately $16.0 million at September 30, 2026, up from approximately $13.8 million at December 31, 2025.


Analysis · ODYS · Technology

Revenue is inflecting: Q3 revenue of $424 thousand was nearly triple the $149 thousand a year earlier, and the $16.0 million backlog gives the company a visible pipeline to convert. Yet the nine-month picture remains ugly — revenue of $926 thousand is down 64% from $2,576 thousand because the prior year included a one-time $1.69 million contract-liability derecognition from a Fortune 500 medical customer, and the net loss widened to $13.7 million from $12.8 million. Cash fell to $22.8 million from $25.7 million at year-end, and management says that funds the operating plan for at least 12 months — meaning another raise is likely before profitability. The filing also reveals a governance tightening: the new bylaws strip stockholders' ability to act by written consent and lower the director-removal threshold to two-thirds, which reduces shareholder leverage.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ODYS was trading at $1.76 on NASDAQ in the Technology sector, with a market capitalization of approximately $36M. The 52-week trading range was $1.64 to $11.30. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ODYS - Latest Insights

ODYS
Aug 24, 2026, 4:05 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $3.68
Real-time Price: $1.76 info
Change: -$1.92 (-52%) info
Market Cap: $36.035M info
ODYS
Aug 21, 2026, 8:50 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.31
Real-time Price: $1.76 info
Change: -$1.55 (-47%) info
Market Cap: $36.035M info
ODYS
Aug 21, 2026, 8:43 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $3.31
Real-time Price: $1.76 info
Change: -$1.55 (-47%) info
Market Cap: $36.035M info
ODYS
Aug 20, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.30
Real-time Price: $1.76 info
Change: -$1.54 (-47%) info
Market Cap: $36.035M info
ODYS
Aug 20, 2026, 2:25 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $3.63
Real-time Price: $1.76 info
Change: -$1.87 (-52%) info
Market Cap: $36.035M info